1-7 of 7
Mitchell Ho
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Development of highly effective anti-mesothelin hYP218 Chimeric Antigen Receptor T cells with increased tumor infiltration and persistence for treating solid tumors

Raffit Hassan, Sakshi Tomar, Jingli Zhang, Manakamana Khanal, Jessica Hong, Abhilash Venugopalan, Qun Jiang, Manjistha Sengupta, Markku Miettinen, Nan Li, Ira Pastan, Mitchell Ho
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther molcanther.MCT-22-0073-A.2022.
DOI: https://doi.org/10.1158/1535-7163.MCT-22-0073
Published: 02 May 2022
View article
PDF
Includes: Supplementary data
Journal Articles

GPC1-targeted immunotoxins inhibit pancreatic tumor growth in mice via depletion of short-lived GPC1 and downregulation of Wnt signaling

Jiajia Pan, Nan Li, Alex Renn, Hu Zhu, Lu Chen, Min Shen, Matthew D. Hall, Min Qian, Ira Pastan, Mitchell Ho
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther molcanther.0778.2021.
DOI: https://doi.org/10.1158/1535-7163.MCT-21-0778
Published: 21 March 2022
View article
PDF
Includes: Supplementary data
Journal Articles

Combination Therapy of Hepatocellular Carcinoma by GPC3-Targeted Bispecific Antibody and Irinotecan is Potent in Suppressing Tumor Growth in Mice

Xin Chen, Yanmin Chen, Rong Liang, Lanxin Xiang, Jingwen Li, Yuankui Zhu, Huixia He, Le Huang, Dianbao Zuo, Weihang Li, Xinjun Liang, Shuang Dong, Sheng Hu, Mitchell Ho, Mingqian Feng
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2022) 21 (1): 149–158.
DOI: https://doi.org/10.1158/1535-7163.MCT-20-1025
Published: 07 January 2022
View article
PDF
Journal Articles

T-Cell Receptor Mimic Antibodies for Cancer Immunotherapy

Zhijian Duan, Mitchell Ho
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2021) 20 (9): 1533–1541.
DOI: https://doi.org/10.1158/1535-7163.MCT-21-0115
Published: 01 September 2021
View article
PDF
Journal Articles

Abstract CN07-02: Immunotoxins targeting GPC3 for liver cancer

Mitchell Ho, Bryan D Fleming, Tim F Greten, Ira Pastan
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2019) 18 (12_Supplement): CN07-02.
DOI: https://doi.org/10.1158/1535-7163.TARG-19-CN07-02
Published: 01 December 2019
View article
Journal Articles

A Human Single-Domain Antibody Elicits Potent Antitumor Activity by Targeting an Epitope in Mesothelin Close to the Cancer Cell Surface

Zhewei Tang, Mingqian Feng, Wei Gao, Yen Phung, Weizao Chen, Amit Chaudhary, Brad St. Croix, Min Qian, Dimiter S. Dimitrov, Mitchell Ho
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2013) 12 (4): 416–426.
DOI: https://doi.org/10.1158/1535-7163.MCT-12-0731
Published: 08 April 2013
View article
PDF
Includes: Supplementary data
Journal Articles

A novel human monoclonal antibody that binds with high affinity to mesothelin-expressing cells and kills them by antibody-dependent cell-mediated cytotoxicity

Yang Feng, Xiaodong Xiao, Zhongyu Zhu, Emily Streaker, Mitchell Ho, Ira Pastan, Dimiter S. Dimitrov
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (5): 1113–1118.
DOI: https://doi.org/10.1158/1535-7163.MCT-08-0945
Published: 13 May 2009
View article
PDF